Dr. James Utley MSc, PhD, CABP, MLS (ASCP), ABAAHP
Dr. James Utley PhD is a board-certified anti-aging scientist and immunohematology expert advancing the convergence of cellular reprogramming, artificial intelligence, and regenerative medicine. As Chief Scientific Officer at Auragens, he directs the development and manufacturing of stem cell therapeutics, translating molecular insights into clinical interventions that extend healthspan and combat age-related decline.
With a distinguished career as a Technical Director and former US Navy Scientist, Dr. Utley orchestrated over 150,000 cellular transfusions and spearheaded Department of Defense initiatives that revolutionized transfusion medicine protocols. A Johns Hopkins-educated Certified Advanced Biotherapies Professional (CABP), he integrates FDA-compliant biomanufacturing with machine learning frameworks to accelerate human longevity research.
Dr. Utley's research focuses on the genomic architecture of aging, with primary publications examining the gene age signature of mesenchymal stem cells (MSCs) as predictive biomarkers for therapeutic efficacy. His work extends to biological countermeasures for deep space exploration, engineering stem cell solutions to mitigate radiation exposure, microgravity-induced degeneration, and accelerated aging in extraterrestrial environments. This research establishes critical technologies for humanity's expansion beyond Earth.
Chief Scientific Officer at Auragens
Dr. James Utley, MSc, PhD, Chief Scientific Officer at Auragens, is a leading expert in the manufacturing and application of mesenchymal stem cells for regenerative medicine. His work at Auragens focuses on translating cutting-edge stem cell research into advanced therapies that can improve patient lives.
The Leader of the Syndicate
Dr. James Utley is the Founder and Chief Researcher of Syndicate Laboratories, a synthetic biology research company dedicated to advancing the intersection of biotechnology, artificial intelligence, and human health. Through a multidisciplinary approach that combines computational biology, regenerative medicine, bioinformatics, and emerging technologies, Syndicate Laboratories develops innovative solutions designed to address some of the most complex challenges in healthcare and life sciences.